UBE2C overexpression in melanoma and its essential role in G2/M transition

Ubiquitin‑conjugating enzyme E2C (UBE2C) is a key regulator of cell cycle progression, and its aberrant expression has been implicated in various malignancies. However, its clinical and biological roles in malignant melanoma is still unclear. In this study, we found a significant high expression level of UBE2C in melanoma by an in silico analysis of The Cancer Genome Atlas (TCGA) database, which was further validated using fresh melanoma samples. The KM plotter showed that UBE2C level was statistically related to the overall survival (OS) of melanoma patients (p<0.01). RNA interference of UBE2C inhibited the growth of melanoma cells via deactivating ERK/Akt signaling pathways, and blocked the G2/M transition through downregulation of both the level and the activity of mitosis promoting factor (MPF), triggering the apoptosis of melanoma cells. Further, silencing of UBE2C significantly inhibited the xenografted tumor growth on nude mice, indicating an important role of UBE2C in melanoma growth in vivo. Together, our results show that UBE2C may serve as a novel prognostic biomarker as well as a potential therapeutic target for melanoma.

• Publication year

  2019

• Venue

  Journal of Cancer

• Publication date

  2019-05-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.7150/jca.32731PMID 31258721PMCID 6584412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptome Analysis Reveals the Negative Effect of 16 T High Static Magnetic Field on Osteoclastogenesis of RAW264.7 Cells

  2020cited by this paper
• Advances in Carbon Nanotubes for Malignant Melanoma: A Chance for Treatment

  2018cited by this paper
• Malignant Melanoma: Beyond the Basics

  2016cited by this paper
• UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines

  2016cited by this paper
• Natural products with therapeutic potential in melanoma metastasis.

  2015cited by this paper
• Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.

  2014cited by this paper
• C2ORF40 suppresses breast cancer cell proliferation and invasion through modulating expression of M phase cell cycle genes

  2013cited by this paper
• Cdks, cyclins and CKIs: roles beyond cell cycle regulation

  2013influential reference
• High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression

  2013cited by this paper
• Targeting the S and G2 checkpoint to treat cancer.

  2012cited by this paper
• Bortezomib stabilizes mitotic cyclins and prevents cell cycle progression via inhibition of UBE2C in colorectal carcinoma.

  2011cited by this paper
• CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.

  2011cited by this paper
• Identification of genes associated with local aggressiveness and metastatic behavior in soft tissue tumors.

  2010cited by this paper
• Overexpression of the E2 ubiquitin–conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation

  2010cited by this paper
• Clinical Implications of Gene Dosage and Gene Expression Patterns in Diploid Breast Carcinoma

  2010cited by this paper
• Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro

  2010cited by this paper
• Recent progress in understanding the pathology of malignant melanoma

  2009cited by this paper
• Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer

  2009cited by this paper
• UbcH10 has a rate-limiting role in G1 phase but might not act in the spindle checkpoint or as part of an autonomous oscillator

  2008cited by this paper
• Sequential E2s drive polyubiquitin chain assembly on APC targets.

  2007cited by this paper
• Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin‐conjugating enzyme E2C gene expression

  2007cited by this paper
• Cyclin B1–Cdk1 Activation Continues after Centrosome Separation to Control Mitotic Progression

  2007cited by this paper
• Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation

  2007cited by this paper
• UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas

  2007cited by this paper
• Mitosis: a matter of getting rid of the right protein at the right time.

  2006cited by this paper
• The processivity of multiubiquitination by the APC determines the order of substrate degradation.

  2006cited by this paper
• Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma.

  2006cited by this paper
• The anaphase promoting complex/cyclosome: a machine designed to destroy

  2006cited by this paper
• Mitogen requirement for cell cycle progression in the absence of pocket protein activity.

  2005cited by this paper
• UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas

  2005cited by this paper
• A novel UbcH10-binding protein facilitates the ubiquitinylation of cyclin B in vitro.

  2005cited by this paper
• Control of DNA synthesis and mitosis by the Skp2-p27-Cdk1/2 axis.

  2004cited by this paper
• The E2-C vihar is required for the correct spatiotemporal proteolysis of cyclin B and itself undergoes cyclical degradation.

  2004cited by this paper
• Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin

  2004cited by this paper
• Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry

  2004cited by this paper
• Cyclin B1 and CDK1: nuclear localization and upstream regulators.

  2003cited by this paper
• Two Ubiquitin-Conjugating Enzymes, UbcP1/Ubc4 and UbcP4/Ubc11, Have Distinct Functions for Ubiquitination of Mitotic Cyclin

  2003cited by this paper
• Cell cycle-dependent expression of mammalian E2-C regulated by the anaphase-promoting complex/cyclosome.

  2000cited by this paper
• Temporal and spatial control of cyclin B1 destruction in metaphase

  1999cited by this paper
• Whose end is destruction: cell division and the anaphase-promoting complex.

  1999cited by this paper
• A ubiquitin-conjugating enzyme in fission yeast that is essential for the onset of anaphase in mitosis

  1997cited by this paper
• Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase.

  1997cited by this paper
• Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation

  1997cited by this paper
• Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor.

  1993cited by this paper
• Universal control mechanism regulating onset of M-phase

  1990cited by this paper

• Transcriptionally distinct malignant neuroblastoma populations show selective response to adavosertib treatment

  2025cites this paper
• De Novo-Designed APC/C Inhibitors Provide a Rationale for Targeting RING-Type E3 Ubiquitin Ligases

  2025cites this paper
• Single-cell RNA sequencing reveals the role of GTF2F2 in ovarian cancer oncogenesis and progression

  2025cites this paper
• Elucidating the molecular mechanisms of the mongolian medicine Ana Gaqi Nari in gastric cancer treatment through a multi-omics-guided experimental validation.

  2025cites this paper
• Development of a novel 4-protein signature for prognostic prediction in hepatitis B virus-induced hepatocellular carcinoma

  2025cites this paper
• Investigating tumour heterogeneity in a melanoma arising in congenital melanocytic nevus using in situ spatial gene expression analysis

  2025cites this paper
• The inhibitory effect of type V transforming growth factor-β receptor antagonist on the proliferation of keloid fibroblasts by suppressing insulin-like growth factor-binding protein 3-interleukin-6 signaling

  2024cites this paper
• UBE2C promotes LUAD progression by ubiquitin-dependent degradation of p53 to inactivate the p53/p21 signaling pathway

  2024cites this paper
• UBE2C promotes malignancy of cutaneous squamous cell carcinoma

  2023cites this paper
• GRIK3 deficiency promotes non-small cell lung cancer progression by the regulation of the UBE2C/CDK1/Wnt signaling pathway.

  2023cites this paper
• TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.

  2023cites this paper
• Comprehensive analysis of UBE2C expression and its potential roles and mechanisms in hepatocellular carcinoma

  2023cites this paper
• Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma

  2023cites this paper
• Identification of transcriptome characteristics of granulosa cells and the possible role of UBE2C in the pathogenesis of premature ovarian insufficiency

  2023cites this paper
• Role of UBE2C in Brain Cancer Invasion and Dissemination

  2023cites this paper
• Combined Inhibition of UBE2C and PLK1 Reduce Cell Proliferation and Arrest Cell Cycle by Affecting ACLY in Pan-Cancer

  2023cites this paper
• KAT2A/E2F1 Promotes Cell Proliferation and Migration via Upregulating the Expression of UBE2C in Pan-Cancer

  2022cites this paper
• Ubiquitin conjugating enzyme E2 C (UBE2C) may play a dual role involved in the progression of thyroid carcinoma

  2022cites this paper
• LINC01194 recruits NUMA1 to promote ubiquitination of RYR2 to enhance malignant progression in triple-negative breast cancer.

  2022cites this paper
• Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer

  2022cites this paper
• Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer

  2022cites this paper
• Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis

  2021cites this paper
• An Update on the Role of Ubiquitination in Melanoma Development and Therapies

  2021influential citation
• The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy

  2021cites this paper
• Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis

  2021cites this paper
• Identification of potential core genes in esophageal carcinoma using bioinformatics analysis

  2021cites this paper
• Single-Cell Transcriptomics Identifies a Unique Entity and Signature Markers of Transit-Amplifying Cells in Human Corneal Limbus

  2021cites this paper
• NCAPG is a Potential Biomarker for Prognosis of Treatment in Children with High-risk Neuroblastoma

  2021cites this paper
• Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma

  2021cites this paper
• UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway

  2021cites this paper
• RNA Sequencing and Bioinformatic Analysis on Retinoblastoma Revealing that Cell Cycle Deregulation Is a Key Process in Retinoblastoma Tumorigenesis

  2020cites this paper
• Transcriptome Analysis Reveals the Negative Effect of 16T High Static Magnetic Field on Osteoclastogenesis of RAW264.7 Cells

  2020cites this paper
• Ubiquitination and Deubiquitination in Melanoma Research and Clinically Relevant Outcomes

  2020cites this paper
• UBE2C mRNA expression controlled by miR-300 and HuR determines its oncogenic role in gastric cancer.

  2020cites this paper
• Identification of potential target genes and crucial pathways in small cell lung cancer based on bioinformatic strategy and human samples

  2020cites this paper
• A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response

  2020cites this paper
• Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis

  2020cites this paper
• UBE2C is a Potential Biomarker for Tumorigenesis and Prognosis in Tongue Squamous Cell Carcinoma

  2020cites this paper
• MicroRNA: Another Pharmacological Avenue for Colorectal Cancer?

  2020cites this paper
• Identification of potential crucial genes associated with the pathogenesis and prognosis of pancreatic adenocarcinoma

  2020cites this paper
• Transcriptome Analysis Reveals the Negative Effect of 16 T High Static Magnetic Field on Osteoclastogenesis of RAW264.7 Cells

  2020cites this paper
• Identification of Hub Genes and Analysis of Prognostic Values in Hepatocellular Carcinoma by Bioinformatics Analysis.

  2020cites this paper
• Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1.

  2019cites this paper